A systematic review of 23 studies found that hyaluronic acid injection had a lower complication rate (9.0%) compared to permanent materials, though all cross-material comparisons relied on indirect evidence.
Penile augmentation procedures have become increasingly common in aesthetic urology, yet clinicians and patients have lacked consolidated safety data to guide decisions. Researchers conducted a comprehensive systematic review and meta-analysis spanning seven databases through December 2024, examining 23 studies (9 randomized controlled trials and 14 observational studies) involving 2,620 participants across 8 countries. The goal was to establish comparative safety profiles across different augmentation modalities and help sexual health practitioners counsel patients with evidence-based information.
The analysis classified complications using the standardized Clavien-Dindo system, which grades surgical complications from minor issues to life-threatening events. The pooled complication rate across all procedures was 14.9%, with substantial variation between techniques (95% CI: 11.5-18.6%). The researchers found statistically significant heterogeneity between different procedure types, indicating that some techniques carried notably different risk profiles than others. Hyaluronic acid (HA) injection emerged with the numerically lowest complication rate at 9.0%, earning a moderate GRADE certainty rating. This was notably lower than permanent materials, which showed higher complication frequencies but had very low certainty ratings due to limited direct evidence.
Regarding efficacy for girth augmentation, outcomes varied considerably by material. Dermal-fat grafts produced modest gains of 1.23 to 1.50 cm, while silicone implants delivered larger increases of 2.50 to 3.50 cm. A critical finding was the absence of head-to-head randomized controlled trials comparing different materials directly. This means all comparisons between techniques are indirect, derived from separate studies using potentially different patient populations, measurement protocols, and follow-up durations. The researchers emphasized that no gold standard exists for patient-reported outcome measures across these procedures, limiting the ability to assess functional or psychological benefits beyond objective measurements.
The reversibility aspect of hyaluronic acid merits consideration in risk assessment. Unlike permanent silicone implants or dermal-fat grafts, HA can be enzymatically dissolved if complications occur or patient satisfaction proves inadequate. This theoretical advantage of "undo-ability" may influence shared decision-making conversations, though the authors note this finding's relevance is primarily to sexual health counseling rather than establishing definitive superiority for any technique.
If you are considering penile augmentation, this evidence suggests several practical considerations:
Safety profile matters first: Complication rates are real. A 14.9% overall rate means roughly 1 in 7 procedures experience some adverse event, though most are minor. If you pursue a procedure, understanding the specific complication profile of your chosen technique should inform consent discussions.
Hyaluronic acid may carry lower immediate risk: The evidence suggests HA injection has a more favorable safety profile than permanent materials based on current available data. However, the moderate GRADE rating (not high) means confidence in this comparison is qualified. You should discuss what complications have been documented with your surgeon and their personal experience with each technique.
Permanence is a trade-off: Larger girth gains come with permanent materials (silicone, dermal-fat), but these carry higher complication rates and lack the reversibility option. Temporary or semi-permanent options provide more modest gains but potentially easier exit strategies if problems arise.
Ask about long-term outcomes: Most published studies are relatively short-term. Ask your surgeon about satisfaction rates beyond 1-2 years, revision rates, and what happens to material over decades. This information appears genuinely sparse in the literature.
Demand validated measurement: The absence of standardized patient-reported outcome measures is a gap. Ask how success will be measured beyond your own subjective experience: Will sensation, erectile function, or partner satisfaction be assessed? Will follow-up be structured or ad hoc?
| Characteristic | Details |
|---|---|
| Study type | Systematic review and meta-analysis |
| Databases searched | 7 databases, inception through December 2024 |
| Studies included | 23 primary studies (9 RCTs, 14 observational) |
| Total participants | 2,620 across 8 countries |
| Complications classified by | Clavien-Dindo system |
| Risk of bias assessment | RoB ver. 2.0, ROBINS-I, Newcastle-Ottawa Scale |
| Registered | PROSPERO (CRD420261374814) |
| Primary outcome | Complication rates by procedure type |
| Secondary outcome | Girth augmentation gains by material |
Penile augmentation procedures: a systematic review and meta-analysis of techniques, materials, and safety outcomes. Sexual Health. PubMed.
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.